Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury

Summary

A non-randomized study evaluating the efficacy of intravesical gentamicin on the occurrence rate of urinary tract infections and bladder complications in patients after spinal cord injury (SCI), and to assess its effectiveness in promoting overall quality of life (QOL), community living, and participation.

Timeline

Start

2018-08-24

Primary completion

2023-09-08

Completion

2023-09-30

Outcome

Met primary endpoint

registry analysis (superiority test); Gentamicin Sulfate; p <0.0001; Risk Ratio (RR) 0.17 (95% CI 0.03 to 0.20); differences in incidence rate ratio NCT03503513 ↗

Drugs

Indications